|
Volumn 97, Issue 4, 2002, Pages 263-267
|
Do neutrophils contribute to myocardial reperfusion injury?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALTEPLASE;
CARBOHYDRATE SELECTIN ANTAGONIST;
CD11B ANTIBODY;
CD18 ANTIBODY;
CY 1503;
HEPARIN;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
LIDOCAINE;
MONOCLONAL ANTIBODY;
NEUTROPHIL INHIBITOR;
PADGEM PROTEIN ANTIBODY;
PLACEBO;
RECOMBINANT HUMAN MONOCLONAL ANTIBODY;
SELECTIN ANTAGONIST;
UNCLASSIFIED DRUG;
ACUTE DISEASE;
ANIMAL MODEL;
CELL DEATH;
CLINICAL TRIAL;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
DRUG HALF LIFE;
HEART INFARCTION;
HEART MUSCLE CELL;
HEART MUSCLE INJURY;
HEART MUSCLE REPERFUSION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERTENSION;
LEUKOCYTE;
NEUTROPHIL;
NONHUMAN;
PATHOPHYSIOLOGY;
REPERFUSION INJURY;
REVIEW;
RISK FACTOR;
IMMUNOLOGY;
HUMAN;
MYOCARDIAL REPERFUSION INJURY;
NEUTROPHILS;
HUMANS;
|
EID: 0035997535
PISSN: 03008428
EISSN: None
Source Type: Journal
DOI: 10.1007/s00395-002-0363-x Document Type: Review |
Times cited : (23)
|
References (48)
|